168 related articles for article (PubMed ID: 1438427)
21. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
22. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia.
Körbling M; Knauf W; Funderud S; Kvalheim G; Hunstein W
Haematologica; 1991 Mar; 76 Suppl 1():29-36. PubMed ID: 1650742
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for the rate of engraftment of neuroblastoma patients autotransplanted with purged marrow.
Ross RE; Jeter EK; Gazitt Y; Laver J
Prog Clin Biol Res; 1994; 389():139-43. PubMed ID: 7700896
[TBL] [Abstract][Full Text] [Related]
24. Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) in patients with lymphoid malignancies receiving unpurged or mafosfamide-purged autografts.
Carlo-Stella C; Mangoni L; Almici C; Meloni G; Mandelli F; Rizzoli V
Behring Inst Mitt; 1991 Dec; (90):69-74. PubMed ID: 1801693
[No Abstract] [Full Text] [Related]
25. [Monoclonal antibody and purging].
Ueda R; Morishima Y
Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
[No Abstract] [Full Text] [Related]
26. Large-scale immunomagnetic separation system for the removal of tumor cells from bone marrow.
Gee A; Moss T; Mansour V; Kulcinski D; Law P; Ishizawa L; Hardwick A
Prog Clin Biol Res; 1992; 377():181-7. PubMed ID: 1438414
[No Abstract] [Full Text] [Related]
27. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
28. A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody.
Rhodes EG; Baker PK; Duguid JK; Davies JM; Cawley JC
Bone Marrow Transplant; 1992 Dec; 10(6):485-9. PubMed ID: 1490198
[TBL] [Abstract][Full Text] [Related]
29. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
[TBL] [Abstract][Full Text] [Related]
30. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
Jansen J; Hanks S; English D; Karaffa R; Akard L
Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
[No Abstract] [Full Text] [Related]
31. Purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma.
Gribben JG; Nadler LM
Important Adv Oncol; 1993; ():139-56. PubMed ID: 8505048
[No Abstract] [Full Text] [Related]
32. Comparison of magnetic particles for immunomagnetic bone marrow purging using an acute lymphoblastic leukaemia model.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Transplant Proc; 1990 Oct; 22(5):2177-8. PubMed ID: 2219335
[No Abstract] [Full Text] [Related]
33. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
34. [Acute leukemia: autologous transplantation of bone marrow cells grown in long-term culture containing low molecular weight natural tumour suppressor].
Yang K; Teng AP; Pei ZT
Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):287-9, 325-6. PubMed ID: 7953919
[TBL] [Abstract][Full Text] [Related]
35. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
Mizuta S; Kawano A
Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
[No Abstract] [Full Text] [Related]
36. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
37. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
[No Abstract] [Full Text] [Related]
38. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
[TBL] [Abstract][Full Text] [Related]
39. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma].
Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W
Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071
[TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
Ball ED; Mills L; Hurd D; McMillan R; Gingrich R
Prog Clin Biol Res; 1992; 377():97-110; discussion 111. PubMed ID: 1438450
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
